Published: 17 April 2019
Author(s): Carmen Adduci, Hussam Ali, Pietro Francia, Riccardo Mantovani, Francesca Palano, Pierpaolo Lupo, Sara Foresti, Guido De Ambroggi, Riccardo Cappato
Issue: April 2019
Section: Narrative Review

The subcutaneous implantable cardioverter defibrillator (S-ICD) is a valuable alternative to the conventional trans-venous ICD (TV-ICD) for the prevention of sudden cardiac death (SCD). Prospective registries showed that the S-ICD is safe and effective in treating ventricular tachyarrhythmias in high-risk patients without pacing indications. While in earlier studies patients implanted with S-ICDs were young and mostly affected by channelopathies, contemporary S-ICD cohorts include patients with severely impaired left ventricular function and significant comorbidities.

Newsletters

Stay informed on our latest news!